14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
ACOG vs BHST: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Alpha Cognition Inc. (ACOG) is the stronger overall head-to-head candidate over BioHarvest Sciences Inc. (BHST) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). ACOG carries a Unified Composite Score of 56.2/100 (HOLD) at $9.00 (26.9x Forward P/E, -141.6% operating margin), whereas BHST carries 58.2/100 (HOLD) at $1.30 (N/M Forward P/E, -18.0% operating margin).
Composite vs. Pillar Nuance: While BHST currently prints a higher short-term Unified Composite Score (58.2/100 HOLD vs. ACOG 56.2/100 HOLD), ACOG captures the overall institutional head-to-head verdict (7–3 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (-141.6% vs. -18.0% operating margin) and revenue trajectory (+173.8% vs. +3.8% YoY).
Technical & Structure Timing Caution: ACOG trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 56.6); meanwhile BHST is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Competes within the Packaged Foods value chain with $29.9M market capitalization and -18.0% operating margin.
OpEx & R&D Reinvestment77.0% of Rev ($27M)
90D Engineering Disclosures0 Published
Investor FAQ ACOG vs BHST Key Questions & Quantitative Answers
As of Nov 20, 2026, Alpha Cognition Inc. (ACOG) is the stronger overall head-to-head candidate over BioHarvest Sciences Inc. (BHST) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). ACOG carries a Unified Composite Score of 56.2/100 (HOLD) at $9.00 (26.9x Forward P/E, -141.6% operating margin), whereas BHST carries 58.2/100 (HOLD) at $1.30 (N/M Forward P/E, -18.0% operating margin). Composite vs. Pillar Nuance: While BHST currently prints a higher short-term Unified Composite Score (58.2/100 HOLD vs. ACOG 56.2/100 HOLD), ACOG captures the overall institutional head-to-head verdict (7–3 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (-141.6% vs. -18.0% operating margin) and revenue trajectory (+173.8% vs. +3.8% YoY). Technical & Structure Timing Caution: ACOG trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 56.6); meanwhile BHST is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
ACOG leads the Growth & Scale pillar: ACOG posts +173.8% YoY revenue growth and +0.0% YoY earnings growth on $20M TTM revenue (93.9% gross margin, -141.6% operating margin), compared with BHST at +3.8% YoY revenue growth and +0.0% YoY earnings growth on $35M TTM revenue (59.0% gross margin, -18.0% operating margin). Across the 3-period historical trajectory (FY2023 to FY2025), ACOG cumulative revenue shifted N/A while BHST shifted +200.0%. In operating R&D and SG&A reinvestment, ACOG deploys N/A (0 90-day corporate R&D disclosures) versus 77.0% of Rev ($27M) (0 disclosures) for BHST.
ACOG screens cheaper on headline valuation multiples. ACOG trades at 26.9x Forward P/E, 26.9x Trailing P/E, N/M PEG, and 9.7x EV/Revenue (unreported FCF margin), whereas BHST trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.7x EV/Revenue (-26.6% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ACOG (-67.6% ROE) versus BHST (-142.5% ROE) capital efficiency.
In options market volatility and institutional positioning, ACOG carries 73.3% implied volatility (50th %ile, Balanced (25th–60th %ile)), a 0.74x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.75β · 63% Vol realized risk). By comparison, BHST carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.25β · 86% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.